Profile
Full Name
Cue Biopharma, Inc.Ticker Symbol
CUEExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
January 2, 2018Indexes
Not includedWebsite
http://www.cuebiopharma.comEmployees
41Key Details
Price
$0.76(-2.43%)
Market cap
$46.99M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$9.29M(+69.16% YoY)
Annual EPS
-$0.72(+35.14% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Cue Biopharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 2, 25 Citizens Capital Markets
Market OutperformAug 20, 24 Stifel
BuyJul 26, 24 Piper Sandler
OverweightJul 26, 24 JMP Securities
Market OutperformApr 9, 24 Stifel
BuyApr 9, 24 Oppenheimer
OutperformApr 3, 24 Piper Sandler
OverweightMar 13, 24 Jefferies
BuyNov 6, 23 Piper Sandler
OverweightJun 15, 23 Stifel
BuyInstitutional Ownership
- What is the ticker symbol for Cue Biopharma?
- Does Cue Biopharma pay dividends?
- What sector is Cue Biopharma in?
- What industry is Cue Biopharma in?
- What country is Cue Biopharma based in?
- When did Cue Biopharma go public?
- Is Cue Biopharma in the S&P 500?
- Is Cue Biopharma in the NASDAQ 100?
- Is Cue Biopharma in the Dow Jones?
- When was Cue Biopharma's last earnings report?
- When does Cue Biopharma report earnings?
- Should I buy Cue Biopharma stock now?
What is the ticker symbol for Cue Biopharma?
The ticker symbol for Cue Biopharma is NASDAQ:CUE
Does Cue Biopharma pay dividends?
No, Cue Biopharma does not pay dividends
What sector is Cue Biopharma in?
Cue Biopharma is in the Healthcare sector
What industry is Cue Biopharma in?
Cue Biopharma is in the Biotechnology industry
What country is Cue Biopharma based in?
Cue Biopharma is headquartered in United States
When did Cue Biopharma go public?
Cue Biopharma's initial public offering (IPO) was on January 2, 2018
Is Cue Biopharma in the S&P 500?
No, Cue Biopharma is not included in the S&P 500 index
Is Cue Biopharma in the NASDAQ 100?
No, Cue Biopharma is not included in the NASDAQ 100 index
Is Cue Biopharma in the Dow Jones?
No, Cue Biopharma is not included in the Dow Jones index
When was Cue Biopharma's last earnings report?
Cue Biopharma's most recent earnings report was on Mar 31, 2025
When does Cue Biopharma report earnings?
The next expected earnings date for Cue Biopharma is May 9, 2025
Should I buy Cue Biopharma stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions